Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT05640596

Antenatal Corticosteroid Therapy: Which Impact on Birth Parameters?

Conditions: Growth Retardation

Sex: All
Ages: N/A – 12 Months
Enrollment: 363
Sponsor: Central Hospital, Nancy, France

Summary

Use of antenatal corticosteroids therapy has increased since the 2000s. The benefits of such a therapy on premature newborns are scientifically and internationally recognized.Nevertheless, few studies have been conducted to investigate the impact of this antenatal corticosteroid therapy on full-term newborns (> 36 weeks' gestation).The aim of this study is to compare the birth parameters of full-term newborns exposed or not to antenatal corticosteroid therapy.

Eligibility Criteria

Inclusion Criteria:all children exposed to an antenatal corticosteroid therapy before 34 weeks of amenorrhea because of a threat of premature deliveryonly full-term newbornsExclusion Criteria:all children exposed to an antenatal corticosteroid therapy before 34 weeks of amenorrhea for other reasons

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05640596). StuddyBuddy aggregates publicly available trial information.